Monthly Archives: May 2009

CONVENTION UPDATE: Focus is on Yields, Technology and Supportive Policy Environment to Meet Food & Fuel Demands

By Val Giddings When Joachim Schneider (Head of Life Sciences for Bayer Crop Science and BIO’s new Chairman for Food & Ad) opened the panel on “Agricultural Production:  Meeting the Sustainability Challenge,” he made it clear that today’s challenge is to increase productivity and while dealing with climate change.  Will future production keep pace with demand?  How can we meet food and fuel challenges? “We need to marry global science with global scale to produce Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,

IP Think Tank Podcast: Biotech Intellectual Property at the Crossroads

Thanks to the IP Think Tank blog, we have a great podcast on Biotech Now where Gregory Glover, a panellist at the 2009 BIO International Convention about the pending Biosimilar legislation and concerns over situations where a follow on product might avoid patent claims but still be able to rely on innovator regulatory data.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

From Jim Greenwood: Things are humming in Atlanta

I arrived Thursday to begin the pre-conference media interviews and to speak at some events that precede the convention like the Association of University Research Parks, the Council of State Bioscience Associations and the Biotechnology Institute. The Institute presented its teacher of the Year award and honors the BioGenius students. It’s always inspiring to meet the next generation of biotech researchers. Early this morning I had the honor of doing a live interview on the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Jim Greenwood and Andrew Young on Fox Business: The Future of Biotechnology

Jim Greenwood and Andrew Young appear on Fox Business to discuss the future of biotechnology.

Jim's Corner  |  Leave a comment  |  Email This Post

China IP Forum to Bring Third Patent Amendment Face-to-Face with Biotechnology Concerns

Emerging markets, particularly the China market, have become a strategic area for pharmaceutical and chemical companies and law firms. China’s lawmakers adopted third revision of the law recently, which will bring a number of substantial changes to the Chinese patent system.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: